Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 5.17
+0.06 (1.17%)
Apr 17, 2026, 3:47 PM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 3.15 billion as of April 17, 2026. Its market cap has decreased by -10.87% in one year.
Market Cap
3.15B
Enterprise Value
3.47B
Revenue
14.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.17
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 3.15B, a decrease of -73.95%. That is a compound annual growth rate of -28.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 3.15B | 27.75% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 4.36B |
| TYK Medicines | 4.24B |
| Antengene Corporation | 4.18B |
| Viva Biotech Holdings | 4.14B |
| Clover Biopharmaceuticals | 4.02B |
| BioDlink International Company | 3.81B |
| AIM Vaccine | 3.73B |
| Mirxes Holding Company | 3.66B |